Utama › Limfoma › Wilayah Columbia › Washington
Kajian klinikal Limfoma di Washington, DC
23 kajian untuk Limfoma sedang mencari peserta di lokasi dalam dan sekitar Washington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Mengambil pesertaFasa 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Mengambil pesertaFasa 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Mengambil pesertaFasa 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Mengambil pesertaFasa 2
- Maryland Oncology Hematology, Silver Spring · 7 mi jauh
Collection of Tissue Samples for Cancer Research
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Mengambil pesertaFasa 1/2
- Children's National Medical Center, Washington D.C.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Mengambil pesertaFasa 3
- Research Site, Bethesda · 7 mi jauh
Sample Collection and Tracking for the Developmental Therapeutics Clinic
Mengambil pesertaKajian pemerhatian
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Mengambil pesertaKajian pemerhatian
- Walter Reed National Military Medical Center, Bethesda · 7 mi jauh
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Mengambil pesertaFasa 3
- Georgetown University, Washington D.C.
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Mengambil pesertaFasa 1/2
- Medstar Georgetown University Hospital, Washington D.C.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Mengambil pesertaFasa 2
- Georgetown University (Data Collection Only), Washington D.C.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Mengambil pesertaFasa 3
- MedStar Georgetown University Hospital, Washington D.C.
Vaccine Responses in Patients With B Cell Malignancies
Mengambil pesertaFasa 4
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Mosaic Trial for Stem Cell Transplant Recipients
Mengambil peserta
- Georgetown University School of Medicine, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- National Institute of Health, Bethesda · 7 mi jauh
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Mengambil pesertaKajian pemerhatian
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauh
Kajian Limfoma di bandar lain
- Houston, TX34 kajian
- Boston, MA33 kajian
- New York City, NY33 kajian
- Baldwin Park, CA21 kajian
- Chicago, IL20 kajian
- Durham, NC17 kajian
- St. Louis, MO15 kajian
- Philadelphia, PA15 kajian
- Cleveland, OH14 kajian
- Edison, NJ12 kajian
- Atlanta, GA12 kajian
- Seattle, WA12 kajian
Kajian lain di Washington
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil55 kajian
- Kanser Payudara46 kajian
- Kanser Metastatik43 kajian
- Kanser Paru-paru41 kajian
- Kanser Prostat38 kajian
- Obesiti33 kajian
- Kanser Kolorektal29 kajian
- Penyakit Kardiovaskular28 kajian
- Kanser Pundi Kencing26 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Ovari23 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.